Our previous studies demonstrated excellent delivery of EphA2 siRNA through 1,2-dioleoyl-sn-glycero-3-phosphatidylcholine (DOPC) neutral nanoliposomes (EPHARNA) to mouse ovarian tumors, which resulted in decreased tumor burden [8]. This evidence concerns the gene EPHA2 and neoplasm.